GNRH1 and prostate carcinoma: The KEGG pathway enrichment analysis revealed several significantly enriched pathways, with particular emphasis on the Hepatitis B, GnRH signaling pathway, EGFR inhibitor resistance, endocrine resistance, and prostate cancer.